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abstract 
Background: Because of the COVID-19 outbreak, the widespread use of Respiratory Protective Devices (RPD) is 
recommended to prevent the spread of infection. This recommendation involves not only healthcare workers but other 
category of workers and the general population as well, in public places, especially where social distancing is difficult 
to maintain. The use of facemasks should not cause physical impairment to individuals, especially for people suffering 
from lung and heart diseases. Objectives: To evaluate the impact of RPDs on the respiratory function in healthy 
and asthmatic subjects, in order to identify the fitness for use mainly, but not only for, occupational purposes during 
COVID-19 outbreak. Methods: Ten individuals were included, three of which affected by asthma and three current 
smokers. A Respiratory Functional Test (RFT) was performed at three times: at the beginning of the work shift 1) 
without wearing and 2) wearing surgical masks, and 3) after 4 hours of usual working activities wearing the masks. 
Arterial Blood Gas (ABG) samples were also tested before the first test and the third test. Results: Observed RFTs 
and ABG parameters did not suffer significant variations, but for Maximal Voluntary Ventilation (P=0.002). Data 
on asthmatic subjects and smokers were comparable to healthy subjects. Discussion: Our results suggest that wearing 
a surgical mask does not produce significant respiratory impairment in healthy subjects nor in subjects with asthma. 
Four hours of continuing mask-wearing do not cause a reduction in breathing parameters. Fitness for use in subjects 
with more severe conditions has to be evaluated individually. Our adapted technique for RFTs could be adopted for 
the individual RPDs fitness evaluation.
riassunto
«Impatto dei dispositivi di protezione delle vie respiratorie sulla funzionalità respiratoria in vista di un 
uso diffuso durante l’epidemia di COVID-19. Una serie di casi». Introduzione: A causa dell ’epidemia di 
COVID-19 si raccomanda un uso diffuso di dispositivi di protezione delle vie respiratorie (RPD) per prevenire la 
diffusione dell ’infezione. Questa raccomandazione coinvolge non solo gli operatori sanitari ma anche altre categorie 
di lavoratori e la popolazione generale nei luoghi pubblici, in particolare dove è difficile mantenere il distanziamento 
sociale. L’uso di maschere non dovrebbe causare danni fisici agli individui, specialmente per le persone che soffrono di 
malattie polmonari e cardiache. Obiettivo: Valutare l ’impatto degli RPD sulla funzione respiratoria in soggetti sani 
e asmatici, al fine di identificare l ’idoneità all ’uso, principalmente ma non solo, a fini professionali durante l ’epidemia 
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di COVID-19. Metodi: Sono stati inclusi dieci soggetti, tre dei quali affetti da asma e tre attualmente fumatori. 
Test di funzionalità respiratoria (RFT) sono stati eseguiti tre volte: all ’inizio del turno di lavoro con e senza indos-
sare una maschera chirurgica, e con la maschera dopo 4 ore di normali attività lavorative. Un’emogasanalisi (EGA) 
è stata effettuata prima del primo e del terzo test. Risultati: I parametri di RFT e EGA osservati non hanno subito 
variazioni significative, eccetto per la ventilazione volontaria massima (P = 0,002). I dati dei soggetti asmatici e 
fumatori sono paragonabili a quelli dei soggetti sani. Discussione: I nostri risultati suggeriscono che indossare una 
maschera chirurgica non produce una compromissione respiratoria significativa in soggetti sani né in soggetti con 
asma o fumatori. Quattro ore di uso della maschera non causano una riduzione dei parametri respiratori. L’idoneità 
all ’uso in soggetti con condizioni più gravi deve essere valutata individualmente, anche attraverso l ’uso della nostra 
metodica per eseguire i RFT.
introduction
The outbreak of Novel Coronavirus disease 
(COVID-19) has become a pandemic, and the 
World Health Organization (WHO) has an-
nounced the highest infectious-disease level (Phase 
6). Control of COVID-19 is a worldwide public 
health problem that governments and individuals 
are trying to overcome (31-33).
International guidance suggests transmission 
through direct and airborne droplets due to aerosol-
generating processes such as talking, coughing, and 
sneezing. The 5 μm diameter threshold used to dif-
ferentiate airborne from direct droplets is an over-
simplification of multiple complex and poorly un-
derstood biological and physical variables (28).
Centers for Disease Control and Prevention 
(CDC), National Institute for Occupational Safety 
and Health (NIOSH), Occupational Safety and 
Health Administration (OSHA), and Food and 
Drug Administration (FDA) sustain it is impor-
tant to recognize that the optimal way to prevent 
COVID-19 transmission is to use a combination of 
interventions such as handwashing, social distanc-
ing, air change, and not just RPD alone. 
In view of the differences in clinical manifesta-
tions (6) and the difficulties in early diagnosis, dur-
ing the COVID-19 outbreak, the extended use of 
Respiratory Protective Devices (RPD) is however 
recommended to prevent the spread of the infec-
tion. The recommendation regards not only health-
care workers (9) but the general population at large, 
in public places, especially where social distancing is 
difficult to apply. 
Generally, the purpose of an RPD is to prevent 
the inhalation of harmful airborne substances or to 
provide a source of respirable air when breathing in 
oxygen-deficient atmospheres. RPDs are used dur-
ing the COVID-19 outbreak both to limit the pos-
sible inhalation of infectious agents and to reduce 
the transmission risk due to droplet emission.
In specific conditions, RPDs are prescribed in oc-
cupational environments by the occupational phy-
sician after a risk assessment and a careful exami-
nation of both individual physical conditions and 
information on RPDs technical characteristics. 
Individuals must be able to wear a respirator with-
out causing them physical impairment (27), and spe-
cial attention must be paid to lung or heart diseases. 
The RPD may harden the breathing effort lead-
ing to earlier dyspnea and fatigue for a given sub-
maximal exercise task (7, 29, 30). This may worsen 
respiratory muscle fatigue when the subject wearing 
an RPD is affected by chronic airways obstruction, 
asthma, interstitial lung diseases, as well as by clini-
cally significant heart disease.
Wearing a respirator mask increases the dead 
space volume, which can increase the depth and fre-
quency of breathing (15, 23). 
Some clinical studies (2, 5, 7, 19) have shown that 
increased resistance and increased dead space can 
lead to a very mild reduction in maximal work per-
formance by approximately 10%.
Regarding groups of individuals with obstruc-
tive or restrictive pulmonary diseases, some Authors 
have found no difference in their exercise perfor-
mance while using a respirator (1, 4, 14, 16, 17, 22). 
It is to be considered that this evidence refers only 
to certain types of respirators such as a half-face air-
purifying respirator, full-face air-purifying respira-
tor, powered air-purifying respirator, supplied-air 
respirators, and others.
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A similar study was conducted by Lucero and 
coll. (18) on military personnel wearing standard 
military M40 protective mask. Military personnel 
with exercise-induced bronchospasm who exercised 
with the M40 protective mask did not overall have 
significantly increased airway hyperreactivity com-
pared to control subjects.
Airways Infection prevention RPD and 
Respiratory Impairment During Their Use
In the health sector, but also in the general liv-
ing environment, two types of RPD are used for 
preventing infections of the airways: N or FFP 
Respirators and Surgical Masks. According to the 
FDA (8), an N95 respirator is an RPD designed to 
achieve a very close facial fit and very efficient fil-
tration of airborne particles. Note that the edges of 
the respirator are designed to form a seal around the 
nose and mouth. Surgical N95 Respirators are com-
monly used in healthcare settings and are a subset of 
N95 Filtering Facepiece Respirators (FFRs), often 
referred to as N95s.
A surgical mask is a loose-fitting, disposable 
device that creates a physical barrier between the 
mouth and nose of the wearer and potential con-
taminants in the immediate environment. These are 
often referred to as face masks, although not all face 
masks are regulated as surgical masks. Note that the 
edges of the mask are not designed to form a seal 
around the nose and mouth. 
In literature, there are few studies regarding the 
assessment of the respiratory function in patients 
with respiratory diseases during the use of the surgi-
cal mask or the filtering facepiece class 2 or 3 (FFP2, 
FFP3) analogous to N95 and N99 Respirators, with 
or without valve.
Gruper and coll. (12) investigated the effect of 
a filtering facepiece class 3 (Pall PF 30) on lung 
function measurements in 92 children and adoles-
cents with bronchial asthma and cystic fibrosis. In 
a randomized sequence, flow-volume curves and 
spirometry were registered in a whole-body ple-
thysmograph. Values measured with filter correlated 
closely to those registered without; individual val-
ues remained close to the line of identity. With high 
flow rates, however, there was a minimal tendency 
towards lower measurements with filter; this damp-
ing effect was flow-dependent and remained of a 
clinically insignificant dimension.
Roberge and coll. (25) assessed the physiological 
impact of the N95 FFR on ten healthy healthcare 
workers. The authors monitored heart rate, respira-
tory rate, tidal volume, minute volume, blood oxy-
gen saturation, and transcutaneous measured pCO2. 
Each subject conducted multiple 1-hour treadmill 
walking sessions, at 1.7 miles/h, and 2.5 miles/h, 
while wearing FFR with exhalation valve, FFR 
without exhalation valve, and without FFR (control 
session). There were no significant differences be-
tween FFR groups and control in the physiological 
variables, exertion scores, or comfort scores. 
The same Authors (26) conducted a similar study 
on healthy subjects wearing a surgical mask as an 
outer barrier added to the N95 FFR. During large-
scale infectious outbreaks, filtering facepiece respi-
rators, such as N95 Masks, may be in short supply. 
The paucity of PPE also happened, in our days, dur-
ing the COVID-19 outbreak. For this reason, some 
authors suggested extending N95 masks’ useful life 
by using a surgical mask as an outer barrier. For in-
stance, Roberge and coll. (26) assessed the physi-
ological impact of this added barrier. They found no 
significant differences in physiological variables be-
tween those who used surgical masks in addition to 
N95 and controls. Added surgical masks decreased 
dead space oxygen concentrations of the filtering 
facepiece respirators at the lesser work rate (P=0.03) 
and for filtering facepiece respirators with an exha-
lation valve at the higher work rate (P=0.003).
Subjective tolerance to respirator use outside of 
traditional industrial settings was also evaluated 
in subjects with mild respiratory impairment (13). 
The results of the study showed that half-face mask 
respirators typically had a more significant adverse 
impact than N95 mask and suggested that the latter 
use may be feasible on a widespread basis if neces-
sary, in the face of epidemic concern.
As for the surgical masks, again, Roberge and 
coll. (24) found that surgical mask use for 1h at a 
low-moderate work rate, in healthy subjects, was not 
associated with clinically significant physiological 
impact or significant subjective perceptions of exer-
tion or heat.
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The effect of using a surgical mask, indicated to 
minimize the risk of cross-infection in patients with 
lung diseases, was studied by Person and coll. during 
the execution of a six minutes walking test (21). Re-
sults suggested that wearing a surgical mask modi-
fies significantly clinical dyspnea without influenc-
ing walked distance.
One more study assessed the influence of surgi-
cal masks on transcutaneous oxygen saturation. The 
authors observed a slight saturation fall only in sur-
gical proceeding with a duration of 60 minutes or 
more. The authors concluded that the small decrease 
of the saturation might be either due to the facial 
mask or the operational stress (3).
In literature, there are very few studies regarding 
respiratory impairment in healthy subjects as well 
as in subjects suffering from obstructive respira-
tory conditions during the use of surgical masks. 
Also, occupational physicians have to express their 
professional opinion regarding the fitness for the 
use of the RPDs in the working population, not 
only in industrial and healthcare settings, and with 
particular regard for workers with pulmonary or 
hearth conditions. A particular concern is that 
RPDs could lead to respiratory discomfort or an 
acute exacerbation of asthma. Thus, we conducted 
an experimental study on a group of ten subjects, 
three of which affected by asthma. We have aimed 
to evaluate the impact of RPDs on the respiratory 
function in healthy and asthmatic subjects, in or-
der to identify the fitness for use mainly but not 




We conducted an experimental case series eval-
uating the impact of a specific RPD (i.e., surgical 
masks) on lung function of 10 subjects. Subjects were 
tested at three times: i) at basal conditions subjects 
performed Respiratory Functional Tests (RFT) and 
had an arterial blood gas test (ABG) without wear-
ing a surgical mask (“basal”); ii) modified basal con-
ditions by wearing a surgical mask (“mask-basal”), at 
this time only RFTs were performed as no substan-
tial changes were expected in the ABG test; iii) after 
4 hours of continuous use of the surgical mask dur-
ing mild-moderate usual working activities (“mask-
active”) subjects repeated RFTs and ABG.
Participants
Ten healthcare workers were included in the study. 
Subjects were equally distributed between males and 
females (five men, five women) with a median age 
of 38.5 ys (range 29-71, 95% CI 33.3-51.1). Most 
of the subjects had a healthy weight with a median 
Body Mass Index of 22.6 kg/m2 (range 18.6-30.1, 
95% CI 20.6-25.5). Four subjects were current 
smokers. Three individuals had asthma: one with 
partially controlled asthma and the other two with 
well-controlled asthma according to GINA evalua-
tion criteria (10). All subjects have been screened for 
COVID-19 infection resulting negative. The char-
acteristics of the sample are reported in Table 1.
Table 1. Demographic characteristics of the ten subjects









1 Medical doctor M 71 87 170 30,1 Yes No
2 Medical doctor M 36 73 179 22,8 No Yes
3 Medical doctor F 39 68 174 22,5 No No
4 Resident F 29 64 172 21,6 Yes No
5 Resident M 30 66 186 19,1 Yes No
6 Nurse M 36 72 163 27,1 No No
7 Medical doctor F 38 73 181 22,3 No No
8 Nurse F 52 59 159 23,3 No Yes
9 Medical doctor M 43 69 171 23,6 No Yes
10 Medical doctor F 48 57 175 18,6 No No
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Surgical mask characteristics 
We used a four layers surgical mask model 
AFLUID®. This model has an external liquid splash 
resistant polyethylene layer, and three non-woven 
layers with a protective, filtering, and non-macer-
ating function. It is recommended in case of pos-
sible transmission of infective viruses via potentially 
contaminated liquids due to a hexagonal structure 
of the polyethylene film (resistant at a pressure of 
16kPa). Masks have one size fitting with a metal 
nose clip. The bacterial filtration efficiency was > 
98%, with a breathing resistance of 79 Pa/cm2, and a 
bioburden ≤ 30 CFU/g according to the norm UNI 
EN 14683:2019. Having four layers, hypothetically, 
the mask is characterized by higher resistance to 
respiratory flows compared to less layered surgical 
masks.
Outcomes
The following RFT parameters were considered: 
Vital Capacity (VC), Forced Vital Capacity (FVC), 
Forced Expiratory Volume at timed interval of 1.0 
second (FEV1), FEV1/FVC, Tidal Volume (TD) 
and Maximal Voluntary Ventilation (MVV). Ac-
ceptability, usability, and repeatability criteria of the 
American Thoracic Society and European Respira-
tory Society were followed (11).
For arterial blood gas (ABG), we determined the 
arterial partial pressure of oxygen (PaO2), the arte-
rial partial pressure of carbon dioxide (PaCO2), and 
the arterial oxygen saturation (SaO2).
Instrumentation
Basal RFTs were performed through the mouth 
according to the standard method recommended 
by the American Thoracic Society (ATS) (9). To 
perform the RFTs wearing the surgical mask, we 
adopted a modified RFT technique. In this tech-
nique, the mouthpiece of the spirometer was modi-
fied by applying a sealed pocket mask (Figure 1). 
The nose was completely sealed by the pressure ap-
plied through the pocket mask to prevent air disper-
sion. To test whether the modified RFT technique 
involves the introduction of a bias, two subjects per-
formed two sequential RFTs using the standard and 
the modified techniques. The various RFT results 
were overlapping with a random mean percentage 
deviation ranging from 0.06% to 2.24%. We used an 
open circuit spirometer from GANSHORN Medi-
zin Electronic GmbH. ABG tests were analyzed 
immediately after sample collection with a New 
GEM Premier 5000 blood gas testing system. 
Statistics
Descriptive analysis was carried out. Categorical 
variables were presented as numbers, and continuous 
data were expressed as medians with interquartile 
ranges (IQR, with 95% CI) as a measure of variabil-
ity. Due to the small sample size, the Krustal-Wallis 
test for non-parametric data was used to assess the 
difference between RFT and ABG values at dif-
ferent times. The Kolmogorov-Smirnov test was 
used for comparison between paired times. Before 
data analysis we tested randomness (P>0.05) and 
checked that all observations were independent. All 
analyses were performed with SPSS (IBM Corp. 
Released 2019. IBM SPSS Statistics for MacOs, 
Version 26.0. Armonk, NY: IBM Corp.)
results
Observed RFTs and arterial blood parameters are 
reported in Tables 2 and 3, and Figures 3A-F. As 
shown in Table 2 and Figures 3A-E, the functional 
parameters usually measured (VC, FVC, FEV1, and 
Figure 1 - The modified Respiratory Function Test tech-
nique. The mouthpiece of the spirometer was modified by 
applying a sealed pocket mask
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FEV1/FVC) did not suffer significant variations. A 
reduction or an increase of FEV1 is considered sig-
nificant when the variation exceeds 20%. FEV1 is 
the most commonly used bronchoprovocation test 
result, as it is easy to test and shows excellent repro-
ducibility. Methacholine concentration at the point 
that FEV1 is decreased to 20% of baseline in the 
dose-response curve is called PC20 (provocation 
concentration causing FEV1 20% fall) and is regard-
ed as an index of the bronchial hyperresponsiveness 
(20). On these bases, we considered as significant a 
variation of 20% or more for all the volumes men-
tioned above.
Therefore, there was no statistically significant 
difference between VC exp (P=0.431), VC insp 
(P=0.087), FVC (P=0.125), FEV1 (P=0.157), FEV1/
FVC (P=0.673), TV (P=0.072) at the different 
times. Even with the presence of an obstacle due 
to the physical structure of the mask, the forced 
respiratory parameters (FVC, FEV1, FEV1/FVC) 
showed no significant reduction (less than 20%). 
The tests performed after 4 hours of use of the mask 
were substantially similar to those recorded during 
“mask-basal”, which proves the absence of a cumu-
lative or progressive phenomenon.
However, MVV showed a statistically significant 
difference between times (P=0.002) (Figure 3F). In 
particular, tests wearing the surgical mask registered a 
reduction from basal condition (basal vs. mask-basal, 
P=0.002; basal vs. mask-active, P=0.041), but did not 
differ at the two times wearing the mask, before and 
after the working activity. (mask-basal vs. mask-active, 
P=0.310). The reduction could be attributed to the 
mechanical barrier of the mask, which becomes no-
ticeable at high rate ventilatory volumes. This is con-
firmed by the lack of significant difference between 
the “mask-basal” and the “mask-active” tests, which 
rules out a respiratory physiological impairment.
Differences for observed ABG values are reported 
in Table 2, and no statistically significant difference 
was found between ABG values at the basal condi-
tion and after 4 hours of the surgical mask active 
wearing (PaO2, P=0.759; PaCO2, P=0.988; SaO2, 
P=0.759) (Figure 4A-C). The absence of a respira-
tory functional load is demonstrated by the constant 
levels of PaO2 and SaO2 during the three tests, while 
Figure 2 - Respiratory Function Test values at basal (1), mask-basal (2), and mask-active (3) times. Circles and asterisks rep-
resent outlier values
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Table 2 - Respiratory Functional Tests values at different times




FVC (Δ) FEV1 (Δ) FEV1/FVC 
(Δ)
TV (Δ) MVV (Δ)
1§ Basal 3.9 3.8 4.2 3.1 72.7 1.4 142.9
Mask-basal 4.0 (0.1) 3.6 (-0.1) 4.0 (-0.3) 2.8 (-0.3) 69.3 (-3.4) 1.1 (-0.3) 104.7 (-38.2)
Mask-active 4.2 (0.1) 3.8 (0.2) 4.0 (0.03) 2.7 (-0.1) 67.7 (-1.6) 1.0 (-0.1) 96.6 (-8.1)
2† Basal 5.3 5.0 5.4 4.5 81.8 4.1 152.5
Mask-basal 4.9 (-0.4) 5.0 (0.1) 5.2 (-0.2) 4.4 (-0.0) 84.6 (2.8) 3.7 (-0.4) 125.5 (-27.0)
Mask-active 4.8 (-0.1) 3.2 (-1.8) 5.1 (-0.1) 4.3 (-0.1) 83.9 (-0.7) 3.6 (-0.1) 145.6 (20.1)
3 Basal 4.7 4.3 4.7 3.7 77.8 2.5 166.1
Mask-basal 3.2 (-1.5) 3.5 (-0.8) 3.8 (-0.9) 2.9 (-0.8) 75.5 (-2.3) 1.2 (-1.3) 76.9 (-89.2)
Mask-active 4.0 (0.8) 3.8 (0.3) 3.9 (0.1) 3.0 (0.1) 76.4 (1.0) 2.2 (1.0) 127.1 (50.3)
4§ Basal 4.1 3.7 4.4 3.8 86.3 2.3 113.8
Mask-basal 4.0 (-0.1) 3.3 (-0.4) 3.8 (-0.6) 3.0 (-0.8) 78.9 (-7.4) 0.9 (-1.4) 51.9 (-61.9)
Mask-active 3.7 (0.3) 3.5 (0.2) 3.9 (0.2) 3.2 (0.2) 80.6 (1.7) 1.2 (0.3) 65.3 (13.4)
5§ Basal 5.6 5.4 6.3 5.7 89.8 2.7 219.0
Mask-basal 5.9 (0.3) 5.4 (0.03) 5.7 (-0.64) 4.2 (-1.4) 74.5 (-15.3) 1.4 (-1.3) 83.6 (-135.4)
Mask-active 4.9 (-0.9) 5.2 (-0.2) 6.0 (0.3) 5.5 (1.2) 91.5 (17.0) 2.2 (0.8) 142.4 (58.8)
6 Basal 4.0 4.0 4.2 3.6 85.2 2.3 133.5
Mask-basal 3.9 (-0.1) 3.5 (-0.5) 3.9 (-0.3) 3.1 (-0.4) 80.0 (-5.2) 2.1 (-0.2) 100.6 (-32.9)
Mask-active 3.8 (-0.04) 2.6 (-0.9) 3.9 (-0.04) 3.2 (0.1) 82.5 (2.6) 2.3 (0.1) 110.5 (9.9)
7 Basal 6.1 5.8 6.2 4.0 63.7 1.8 136.3
Mask-basal 5.3 (-0.8) 3.0 (-2.8) 5.7 (-0.5) 3.6 (-0.3) 63.2 (-0.5) 1.2 (-0.6) 71. 6 (-64.7)
Mask-active 5.0 (-0.4) 4.7 (1.7) 5.9 (0.2) 3.8 (0.1) 63.5 (0.3) 1.2 (0.01) 62.1 (-9.5)
8† Basal 4.1 4.0 4.1 3.0 73.3 2.9 117.5
Mask-basal 3.8 (-0.3) 3.5 (-0.5) 3.9 (-0.3) 2.7 (-0.3) 71.3 (-2.0) 1.3 (-1.6) 96.7 (-20.8)
Mask-active 4.0 (0.2) 3.6 (0.1) 3.9 (0.01) 2.8 (0.03) 71.7 (0.4) 1.1 (-0.2) 86.4 (1.2)
9† Basal 5.3 4.8 5.6 3.6 64.4 3.6 134.0
Mask-basal 4.6 (-0.7) 3.7 (-1.1) 4.7 (-0.9) 3.1 (-0.5) 65.7 (1.3) 3.1 (-0.5) 82.3 (-51.7)
Mask-active 5.3 (0.7) 3.7 (-0.04) 5.4 (0.7) 3.2 (0.2) 60.0 (-5.7) 2.5 (-0.6) 83.5 (-10.3)
10 Basal 3.8 2.5 4.3 3.5 82.0 3.0 97.1
Mask-basal 3.3 (-0.5) 3.5 (0.9) 4.0 (-0.3) 3.4 (-0.1) 84.1 (2.1) 2.0 (-1.0) 52.2 (-44.9)
Mask-active 3.6 (0.3) 3.5 (0.05) 4.1 (0.1) 3.4 (0.04) 83.6 (-0.5) 3.2 (1.2) 77.8 (25.6)
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PaCO2 shows a slight increase, hypothetically due to 
the albeit minimal increase in the respiratory dead 
space produced by the presence of the mask and to 
the small expected rise of CO2 concentration inside 
the same.
Data on asthmatic subjects and smokers were 
comparable to healthy subjects (Figure 4A-B).
discussion
Our results suggest that wearing a surgical mask 
does not produce significant respiratory impairment 
in healthy subjects. Mainly, the functional param-
eters measured did not suffer significant variations. 
Only the observed reduction of MVV appears to be 
significant, and it may be explained by the mechani-
cal barrier provided by the mask, which became no-
ticeable only at high rate ventilatory volumes. We 
also observed the difficulty in performing this test, 
especially the first time, with the adapted technique, 
even in compliant subjects. This parameter, however, 
is of interest for the assessment of the ventilation 
only during intense physical activity. Therefore, we 
consider useful to extend, in further studies, our 
technique to a group of subjects tested during physi-
cal effort.
Our results suggest that using the surgical mask 
does not cause a physiological respiratory impair-
Table 3 - Arterial Blood Gas values at different times
ID# TIME pO2 pCO2 SaO2
1§ Basal 96 32 98.9
Mask-active 97 (1) 36 (4) 98.9 (0.0)
2† Basal 101 40 99.3
Mask-active 101 (0) 41 (1) 99.1 (-0.2)
3 Basal 95 40 99.0
Mask-active 94 (-1) 41 (1) 98.8 (-0.2)
4§ Basal 100 38 99.0
Mask-active 98 (-2) 37 (-1) 99.6 (0.6)
5§ Basal 96 42 98.8
Mask-active 93 (-3) 41(-1) 98.8 (0.0)
6 Basal 90 36 98.1
Mask-active 93 (3) 38 (2) 99.3 (1.2)
7 Basal 127 39 99.2
Mask-active 112 (-15) 37 (-2) 100 (0.8)
8† Basal 108 37 99.3
Mask-active 106 (-2) 37 (0) 99.3 (0.0)
9† Basal 109 42 99.1
Mask-active 94 (-15) 41 (-1) 98.9 (-0.2)
10 Basal 92 38 99.3
Mask-active 88 (-4) 39 (1) 99.6 (0.3)
Figure 3 - Arterial Blood Gas test values at basal (1) and mask-active (2) times. Circles represent outlier values.
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ment in healthy subjects nor well-controlled asth-
matic subjects and smokers during mild-moderate 
working activity. However, further evidence is 
needed to extend this evaluation to subjects or ac-
tive workers affected by uncontrolled asthma, other 
severe chronic pulmonary impairment, and critical 
heart diseases. Moreover, our findings are not en-
tirely applicable to high-intensity physical activity.
In summary, healthy workers, as well as workers 
with controlled or mild asthma, can safely wear sur-
gical masks during their usual activities at least for 
four hours continuously. For those with more severe 
conditions, the evaluation has to be individually ex-
pressed by the occupational physician, possibly after 
a clinical and functional examination. Our adapted 
technique could be adopted for individual RPDs fit-
ness evaluation.
The main limit of our study is the small num-
ber of subjects included. Unfortunately, during the 
COVID-19 pandemic, it is not advised to use po-
tential aerosol-generating procedures such as RFTs. 
Therefore, we underline that our volunteers were all 
selected among healthcare workers as they have all 
been tested for SARS-CoV-2. Thus, the test was 
conducted safely using an open-circuit spirometer 
with adequate filters without the risk of spreading 
the infection. Anyway, thanks to the high heteroge-
neity of our sample, our results seems to be reason-
ably applicable to the general population.
Besides, all our participants were healthcare pro-
fessionals, already practical with traditional RFTs. 
Consequently, the tests were conducted with ad-
equate compliance with the correct technique. Of 
notice, the subjects declared that they experienced 
minor difficulties in performing the RFTs with the 
modified technique. RFTs slightly improved during 
the last test, probably as subjects became more fa-
miliar with the modified technique.
Another limit is that there are many types of 
RPDs in commerce, and our results refer to only 
one type of surgical mask. However, we have cho-
sen a four-layer face mask, which is characterized 
Figure 4 -  FVC and FEV1 median percentage variation between healthy, smokers, and asthmatic subjects at basal, mask-basal, 
and mask-active times
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by higher resistance to respiratory flows, therefore 
considering the worst-case scenario. Further studies 
are needed on a larger number of subjects.
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